Reta (Glp3r) 10mg

Retatrutide is a synthetic peptide designed for metabolic and endocrine research. It functions as a triple receptor agonist at the GIP, GLP-1, and glucagon receptors. Researchers commonly use it in studies of weight loss and metabolic peptides. Researchers investigate how the simultaneous activation of these pathways influences metabolic outcomes, glucose control, and overall energy balance in metabolic dysregulation and energy balance models.

Retatrutide is used in preclinical models to explore how coordinated receptor activation can impact glucose metabolism, lipid accumulation, appetite regulation, and systemic energy regulation. All applications are strictly for laboratory studies and preclinical research use only.